QKI modulates RNA splicing and deregulation of its expression has been associated with
tumorigenesis in several cancers. However, the contribution of QKI to T-cell lymphoblastic leukaemia
(T-ALL) is largely unknown. Here, we investigate QKI expression in T-ALL samples and identify QKI
targets in the context of T-cells. Using T-ALL cell lines we then characterize splicing changes relevant
to T-cell biology.